# Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA)

> **NCT07318350** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 174 (estimated)

## Conditions studied

- Moderate Asthma

## Interventions

- **DRUG:** N0783
- **DRUG:** Alenia® (Formoterol 6 mcg / Budesonide 200 mcg)

## Key facts

- **NCT ID:** NCT07318350
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2028-03
- **Final completion:** 2028-09
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07318350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07318350, "Study of Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg in Patients With Asthma (FORASMA)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07318350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*